AML is one of the most malignant diseases threatening the health worldwide and our previous study found that the genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of AML patients (31). This evidence concerns the gene IL1B and glycogen storage disease VI.